From the provision of supplies to hospitals to ensuring that Australia’s radiation safety isn’t compromised, ARPANSA has been playing a part in helping to maintain essential services during the pandemic.
ARPANSA has released a consultation draft of the new safety standard for exposure to radiofrequency electromagnetic energy – also known as radio waves.
ARPANSA has released an action plan outlining activities that will be undertaken as part of the Australian Government’s Electromagnetic Energy (EME) Program.
Earlier this year, the Australian Communications and Media Authority (ACMA) measured the level of radiofrequency electromagnetic energy (RF EME) the public is exposed to at 59 small cell sites across Australia.
Water can include naturally-occurring radioactive material leached from rocks and soil, and it’s important that guidelines are in place to ensure the safe management of our water supply.
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) has issued a product warning to advise consumers of the dangers of portable devices that emit ultraviolet radiation (UVR).
ARPANSA’s Dr Ken Karipidis chaired a committee of the International Commission on Non-Ionising Radiation Protection (ICNIRP) to develop a statement on exposure to non-ionising radiation for cosmetic purposes.
ARPANSA’s Australian Clinical Dosimetry Service (ACDS) has carried out audits on a new Elekta Unity MRI-Linac in Townsville, Queensland before the treatment of the first patient.
Do you use, or are you exposed to radiation as part of your work? Our new suite of occupational exposure factsheets have been designed to keep you informed about the type of radiation you may be exposed to, any possible health effects and how to adequately protect yourself.
With the novel coronavirus (COVID-19) pandemic, some members of the public are concerned about the human immune system and whether it can be compromised by wireless telecommunications sources such as 5G.
On 27 March 2020, the CEO of ARPANSA, Dr Carl-Magnus Larsson, removed a licence condition from the ANSTO Nuclear Medicine (ANM) facility, allowing it to return to routine operation.
ARPANSA has again collated data from radiation regulators around the country to provide a report on radiation safety and identify opportunities for improvement in the safe use of radiation, particularly in the medical sector.
The radiation dose from a CT scan, while low, is nonetheless assumed to contribute a small additional risk to a patient’s lifetime risk of cancer. ARPANSA's new reference levels show patients in Australia are receiving much lower doses than 5-10 years ago.
ARPANSA staff Sandra Sdraulig and Dr Stuart Henderson recently travelled to Antarctica to support ongoing monitoring of radionuclides and ultraviolet (UV) radiation in the environment.
